X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.70
Delayed Data
As of Apr 25
 0.00 / 0.00%
Today’s Change
1.61
Today|||52-Week Range
4.14
-25.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
AssetsCash6.7M6.3M6.1M5.8M
 
 
 
 
 
Cash & Short Term Investments6.7M6.3M6.1M6.1M
 
 
 
 
 
 
ReceivablesReceivables------27.0K
 
 
 
InventoriesInventories------0.00--
 
Current AssetsPrepaid Expenses------85.0K
 
 
Other Current Assets649.4K466.6K358.6K0.00
 
 
 
 
Current Assets7.4M6.8M6.4M6.2M
 
 
 
 
 
 
Total AssetsIntangible Assets------380.0K
 
 
Other Assets389.0K379.7K380.6K380.0K
 
 
 
 
 
Total Assets7.8M7.2M6.8M6.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable------4.0K
 
 
Accrued Expenses------276.0K
 
 
Other Current Liabilities542.6K381.7K285.7K276.0K
 
 
 
 
 
Other Liabilities542.6K381.7K285.7K300.0K
 
 
 
 
 
 
Total LiabilitiesOther Liabilities3.7M4.7M2.9M2.7M
 
 
 
 
 
Total Liabilities4.3M5.1M3.2M3.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock----0.000.00--
Common Equity3.5M2.1M3.6M3.6M
 
 
 
 
 
Total Shareholder Equity3.5M2.1M3.6M3.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding5.1M5.1M5.1M5.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.